Tirzepatide
Dual GLP-1 and GIP receptor agonist.
View treatment
Compounded oral semaglutide online · English & SpanishOral Semaglutide
Compounded oral-dissolving tablet · once daily · prescription required
From $215/4 weeks
$1,290 upfront for 24 weeks
An option to discuss if you prefer to avoid injections. A licensed clinician reviews whether this compounded daily tablet fits your needs, explains its limitations and sets your dose. It is not an FDA-approved oral medicine.
REMEVi offers its compounded GLP-1 program in 49 states and Washington, DC. It is not available in Louisiana. Your provider must be licensed in the state where you receive care.
Start the oral questionnaire Not sure? Compare tablet vs injectionYour provider determines whether treatment is right for you. Your price every 4 weeks stays the same at every dose.
- No insurance required
- Licensed U.S. providers
- Pharmacies we name
- Founded by patients
- Fast, discreet shipping
- Unlimited follow-up with your clinician
$0 Membership fees
Quick answers
How much does REMEVi cost?
| Medication | 24-week plan | 12-week plan | Every 4 weeks |
|---|---|---|---|
| Oral semaglutide | $215 per 4 weeks | $229 per 4 weeks | $249 per 4 weeks |
Your price never goes up: same at every dose and every renewal of your plan. No membership fee. Compounded medications are not FDA-approved.
What’s included in the price?
Your plan price includes the clinician evaluation and follow-up, the medication if it is prescribed, injection or dosing supplies, shipping, the GLP-1 lab tests your clinician requires, and care coordination in English or Spanish. The health questionnaire is free, and there is no separate membership fee.
Where is REMEVi available?
REMEVi’s GLP-1 program is available in 49 states and Washington, DC. It is not available in Louisiana. Care happens online, so there is no clinic to visit, and medication ships to your door. The clinician who reviews your questionnaire must be licensed in the state where you receive care. See the state-by-state list.
Can I do everything in Spanish?
Yes. The intake questionnaire, the clinical evaluation, your dosing instructions, the patient portal, billing, and our care coordinators and support are all available in Spanish. You choose English or Spanish when you start, and you can switch languages at any time.
Who prescribes, and which pharmacy fills it?
Clinicians in the OpenLoop network who are licensed in your state review your questionnaire and decide whether a prescription is appropriate. If one is prescribed, a state-licensed US 503A compounding pharmacy prepares it: RedRock Pharmacy (Utah), Health Warehouse (Kentucky), Precision Medicine (New York) or Triad Rx (Alabama). See our pharmacy partners. Compounded medications are not FDA-approved.
How long until my medication ships?
Median 3.6 days from payment to shipment (1.9–7.0 days for the middle half of orders; 33 orders, July–September 2026). The pharmacy order was placed a median of 0.7 days after payment (41 orders). Carrier delivery time comes after shipment. Your timing can differ.
Prefer to avoid injections?
Start here.
REMEVi’s clinical protocol considers compounded oral semaglutide generally less effective than injectable semaglutide at the doses used. The large oral trials studied different swallowed formulations; they do not establish equivalent results for this compounded tablet. Discuss the tradeoff if avoiding injections is a priority.
This tablet may be worth discussing when needle avoidance matters to you, but convenience does not establish clinical suitability. Your history, medicines and goals still guide the decision.
A complete program price.
No separate membership fee or increase for a higher prescribed dose.
The monthly plan is billed every 4 weeks. The 12-week and 24-week plans are prepaid for the full term, with the total charge shown before you choose. Review the renewal terms at checkout and in your patient portal.
See the pricing overview- Clinical review & follow-up
- An evaluation of your history, medicines and suitability, with ongoing clinical follow-up.
- Medication & shipping
- If prescribed, daily tablets supplied in four-week cycles with shipping included.
- Required labs
- Lab tests required by your clinician for the GLP-1 program are included in your plan price.
- Bilingual support
- Care coordination in English and Spanish.
How it works
Same molecule, taken a different way.
Semaglutide acts on GLP-1 receptors involved in appetite and fullness. Formulation and route matter: a dissolving tablet, a swallowed tablet and an injection are not interchangeable.
GLP-1 receptor activity
The molecule acts on receptors involved in appetite. That mechanism alone does not establish how well a particular compounded tablet is absorbed or how much weight someone will lose.
Your exact preparation
Follow the pharmacy label for placement in the mouth, food and drink timing, and storage. Ask your pharmacist rather than using instructions for a different oral product.
Clinician-set dose
The listed protocol levels are 5 → 10 mg daily. Your clinician decides whether and when to change the level; do not convert an injectable dose into a tablet dose.
The evidence
What the trials measured — and what they didn't.
A swallowed formulation, not this dissolving tablet.
OASIS 1 studied daily oral semaglutide 50 mg with lifestyle intervention in 667 adults with overweight or obesity without diabetes. At 68 weeks, average weight reduction was 15.1% versus 2.4% with placebo. It did not study REMEVi’s compounded oral-dissolving tablet.
15.1% Average reduction in the studied formulation
68 weeks 50 mg swallowed formulation · 667 participants
Source: Knop et al. OASIS 1. The Lancet, 2023. DOI: 10.1016/S0140-6736(23)01185-6.
Do not assume the same result.
A different formulation, dose and route can change drug exposure. Large trials of swallowed oral semaglutide do not establish equivalent absorption, safety or effectiveness for compounded dissolving tablets. REMEVi’s clinical protocol considers compounded oral semaglutide generally less effective than injectable semaglutide at the doses used.
Different Formulation and route
Individual Clinical decision, not a trial-result promise
Source: OASIS 1 trial; FDA compounding guidance; REMEVi clinical protocol.
The trial was funded by Novo Nordisk and studied a swallowed formulation, not REMEVi compounded tablets. Individual results vary. Compounded medications are not FDA-approved.
How REMEVi works
Care from the first question through follow-up.
See If You Qualify
A licensed provider decides whether treatment is appropriate — nobody is prescribed automatically.
-
Step 1Medical intake
Start the free health questionnaire and review your plan’s full charge before authorizing payment.
About 2 minutes -
Step 2Clinician review
A licensed provider in your state reviews your intake and prescribes only if it is clinically appropriate.
Timing depends on the clinical review -
Step 3Pharmacy and shipping
If prescribed, the dispensing pharmacy prepares your medication and provides storage and administration instructions for the exact formulation.
Preparation and delivery times vary -
Step 4Follow-up, in your language
Message your care team as often as you need for dose adjustments and side-effect support, in English or Spanish.
As your care plan requires
A live visit, labs or additional clinical information may be needed. Approval and delivery dates are not guaranteed.
Your prescription
sets the instructions.
The compounded oral-dissolving tablet is taken daily as prescribed. Follow your pharmacy label for its exact placement in the mouth, food and drink timing, and storage. Ask the pharmacist if anything is unclear; do not substitute instructions for a swallowed tablet.
These are REMEVi’s listed protocol levels, not the doses of a swallowed formulation studied in a trial.
Level 15 mgDaily, only as prescribed
Level 210 mgDaily, only as prescribed
Your prescriber must review and direct any switch, including the starting dose and timing. Do not combine preparations, convert doses yourself or assume an account change is a clinical authorization.
Discuss the risks
before starting.
FDA safety informationNausea, vomiting, diarrhea, constipation and abdominal discomfort can occur with semaglutide. Tell your clinician about persistent symptoms and all medical conditions. Seek urgent care for severe or persistent abdominal pain, signs of a serious allergic reaction, or inability to keep fluids down. A compounded tablet has not undergone FDA premarket safety review.
Tell your clinician about a personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy or pregnancy plans, severe digestive conditions, pancreatitis, gallbladder disease and all medicines you take. Do not assume taking a medicine without injections removes its risks.
No. It is not FDA-approved or an approved generic of another oral medicine. Different formulations and administration routes are not interchangeable. A pharmacy license does not establish the safety or effectiveness of an individual preparation.
Explore other treatments
Semaglutide
The most-studied GLP-1 for weight management.
View treatment
Oral semaglutide
Daily tablet for needle-free dosing.
NAD+ injections
Replenish NAD+, which declines with age.
View treatment
Sermorelin
Stimulates the pituitary's own growth hormone.
View treatment
Glutathione
Antioxidant support against oxidative stress.
View treatmentOral semaglutide questions, answered.
How do I take the oral tablet?
The compounded oral-dissolving tablet is taken daily as prescribed. Follow your pharmacy label for its exact placement in the mouth, food and drink timing, and storage. Ask the pharmacist if anything is unclear; do not substitute instructions for a swallowed tablet.
What strengths are listed?
The REMEVi oral protocol lists 5 mg and 10 mg daily levels. Your clinician chooses the level and timing of any change. Milligram doses cannot be converted directly between oral-dissolving, swallowed and injectable preparations.
Is the tablet as effective as the injection?
REMEVi’s clinical protocol considers compounded oral semaglutide generally less effective than injectable semaglutide at the doses used. The large oral trials studied different swallowed formulations; they do not establish equivalent results for this compounded tablet. Discuss the tradeoff if avoiding injections is a priority.
What side effects should I discuss?
Nausea, vomiting, diarrhea, constipation and abdominal discomfort can occur with semaglutide. Tell your clinician about persistent symptoms and all medical conditions. Seek urgent care for severe or persistent abdominal pain, signs of a serious allergic reaction, or inability to keep fluids down. A compounded tablet has not undergone FDA premarket safety review.
Can I switch between oral and injectable treatment?
Your prescriber must review and direct any switch, including the starting dose and timing. Do not combine preparations, convert doses yourself or assume an account change is a clinical authorization.
Is compounded oral semaglutide FDA-approved?
No. It is not FDA-approved or an approved generic of another oral medicine. Different formulations and administration routes are not interchangeable. A pharmacy license does not establish the safety or effectiveness of an individual preparation.
What does the price include?
Medication if prescribed, evaluation, follow-up, shipping, bilingual support and required program labs. No separate membership fee or price increase with dose. $1,290 upfront for 24 weeks; $687 upfront for 12 weeks; $249 billed every 4 weeks.
Do I need labs?
Your clinician determines which labs are needed and whether recent results can be used. Lab tests required by your clinician for the GLP-1 program are included in your plan price.
Answers for your next step.
A different format.
A clinical decision.
Semaglutide Oral · $1,290 upfront for 24 weeks
Start the oral questionnaireFree questionnaire. No card to start. Prescription only if clinically appropriate.
You can cancel future renewals without a cancellation fee. Prepaid terms are paid in advance; refund eligibility is governed by the Cancellation & Refund Policy.
Cancellation & refund policyThe GLP-1 Guide · Free
Not ready to start today? Take the guide with you.
What GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.
REMEVi offers its compounded GLP-1 program in 49 states and Washington, DC. It is not available in Louisiana. Your provider must be licensed in the state where you receive care.
Medically reviewed by Linda West-Conforti, RN · CA RN #389453 ·
Semaglutide Oral$1,290 upfront for 24 weeksStart questionnaire